authors
- Kishnani, P
- Tarnopolsky, Mark
- Sivakumar, K
- Byrne, B
- Goker-Alpan, O
- Guter, K
- Pervaiz, M
- Dasouki, M
- Levine, T
- Roberts, M
- Johnson, FK
- Sitaraman, S
- Khanna, R
- Flanagan, J
- Sjoberg, ER
- Valenzano, KJ
- Lockhart, DJ
- Boudes, P
T.P.45 An ongoing phase 2a study to investigate drug–drug interactions between escalating doses of AT2220 (duvoglustat hydrochloride) and acid alpha glucosidase in subjects with Pompe disease – Preliminary results
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- October 2012
has subject area
- 1103 Clinical Sciences (FoR)
- 1109 Neurosciences (FoR)
- 1116 Medical Physiology (FoR)
- Neurology & Neurosurgery (Science Metrix)
published in
- Neuromuscular Disorders Journal